Functional Regulatory Role of STAT3 in HPV16-Mediated Cervical Carcinogenesis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Shukla, Shirish ^a,d   Mahata, Sutapa ^a   Shishodia, Gauri ^a   Pandey, Arvind ^a   Tyagi, Abhishek ^a   Vishnoi, Kanchan ^a   Basir, Seemi F ^b   Das, Bhudev C ^c   Bharti, Alok C ^a  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c UNIVERSITY OF DELHI   (India)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN;

ARTICLE; CANCER CELL; CANCER CONTROL; CANCER INHIBITION; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; PAPILLOMAVIRUS INFECTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; UTERINE CERVIX CANCER;

CARCINOGENESIS; CASPASE 3; CELL LINE, TUMOR; CURCUMIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, VIRAL; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TETRAZOLIUM SALTS; THIAZOLES; TYRPHOSTINS; UTERINE CERVICAL NEOPLASMS;

EID: 84880428468     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067849     Document Type: Article

References (61)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. NCRP (2008) Atlas of Cancers in India.
3. Das BC, Sharma JK, Gopalakrishna V, Luthra UK, (1992) Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 73 (Pt 9): 2327-2336.
4. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, et al. (2009) Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 130: 222-233.
5. Balkwill F, Mantovani A, (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV, (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
7. zur Hausen H, (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
8. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R, (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421.
9. O'Conner M, Chan SY, Bernard HU (1995) Transcription factor binding sitesin the long control regions of genital HPVs. In: G M, Bernard HU, Delius H, Baker C, Icenogle J et al., editors. Human Papillomaviruses, 1995, Compendium. Los Alamos: Los Alamos National Library. p21-40.
10. Offord EA, Beard P, (1990) A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J Virol 64: 4792-4798.
11. Rosl F, Das BC, Lengert M, Geletneky K, zur Hausen H, (1997) Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol 71: 362-370.
12. Libermann TA, Zerbini LF, (2006) Targeting transcription factors for cancer gene therapy. Curr Gene Ther 6: 17-33.
13. Cripe TP, Haugen TH, Turk JP, Tabatabai F, Schmid PG 3rd, et al (1987) Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. Embo J 6: 3745-3753.
14. Arany I, Grattendick KG, Tyring SK, (2002) Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5'-segment of the upstream regulatory region (URR). Antiviral Res 55: 331-339.
15. Thierry F, (2009) Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 384: 375-379.
16. Shukla S, Shishodia G, Mahata S, Hedau S, Pandey A, et al. (2010) Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol Cancer 9: 282.
17. Mahata S, Maru S, Shukla S, Pandey A, Mugesh G, et al. (2012) Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells. BMC Complement Altern Med 12: 15.
18. Werness BA, Levine AJ, Howley PM, (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
19. Dyson N, Howley PM, Munger K, Harlow E, (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
20. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, et al. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J 8: 4099-4105.
21. Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, et al. (2007) Stat3 activation in human endometrial and cervical cancers. Br J Cancer 96: 591-599.
22. Takemoto S, Ushijima K, Kawano K, Yamaguchi T, Terada A, et al. (2009) Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. Br J Cancer 101: 967-972.
23. Yang SF, Yuan SS, Yeh YT, Hung SC, Wu MT, et al. (2006) Positive association between STAT3 and Ki-67 in cervical intraepithelial neoplasia. Kaohsiung J Med Sci 22: 539-546.
24. Yang SF, Yuan SS, Yeh YT, Wu MT, Su JH, et al. (2005) The role of p-STAT3 (ser727) revealed by its association with Ki-67 in cervical intraepithelial neoplasia. Gynecol Oncol 98: 446-452.
25. Rajkumar T, Rajan S, Baruah RK, Majhi U, Selvaluxmi G, et al. (1998) Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix. Eur J Gynaecol Oncol 19: 556-560.
26. Vijayalakshmi N, Selvaluxmi G, Majhi U, Rajkumar T, (2007) Alterations found in pl6/Rb/cyclin D1 pathway in the dysplastic and malignant cervical epithelium. Oncol Res 16: 527-533.
27. Giannoudis A, Herrington CS, (2000) Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses. Cancer 89: 1300-1307.
28. Feng W, Xiao J, Zhang Z, Rosen DG, Brown RE, et al. (2007) Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod Pathol 20: 961-966.
29. Baak JP, Kruse AJ, Garland SM, Skaland I, Janssen EA, et al. (2005) Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions. Am J Surg Pathol 29: 1062-1066.
30. Salcedo M, Taja L, Utrera D, Chavez P, Hidalgo A, et al. (2002) Changes in retinoblastoma gene expression during cervical cancer progression. Int J Exp Pathol 83: 275-286.
31. Schmitt M, Dalstein V, Waterboer T, Clavel C, Gissmann L, et al. (2010) Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Res 70: 249-256.
32. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL, (2002) Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 94: 2199-2210.
33. Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, et al. (2004) Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Mol Diagn 8: 57-64.
34. Smotkin D, Wettstein FO, (1987) The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 61: 1686-1689.
35. Jiang M, Milner J, (2002) Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21: 6041-6048.
36. Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, et al. (2003) In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther 8: 762-768.
37. Hall AH, Alexander KA, (2003) RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 77: 6066-6069.
38. Sima N, Wang S, Wang W, Kong D, Xu Q, et al. (2007) Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Gynecol Oncol 106: 299-304.
39. Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, et al. (2008) New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther 15: 140-153.
40. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, et al. (2003) siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22: 5938-5945.
41. Gu W, Putral L, Hengst K, Minto K, Saunders NA, et al. (2006) Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther 13: 1023-1032.
42. Munagala R, Kausar H, Munjal C, Gupta RC, (2011) Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 32: 1697-1705.
43. Niu G, Wright KL, Ma Y, Wright GM, Huang M, et al. (2005) Role of Stat3 in regulating p53 expression and function. Mol Cell Biol 25: 7432-7440.
44. Vultur A, Arulanandam R, Turkson J, Niu G, Jove R, et al. (2005) Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen. Mol Biol Cell 16: 3832-3846.
45. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, et al. (2006) Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 66: 2544-2552.
46. Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, et al. (1994) p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A 91: 5320-5324.
47. Grivennikov SI, Karin M, (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21: 11-19.
48. Fu XY, (2006) STAT3 in immune responses and inflammatory bowel diseases. Cell Res 16: 214-219.
49. Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, et al. (2009) Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15: 114-123.
50. Darnell JE Jr, (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2: 740-749.
51. Ghoreschi K, Laurence A, O'Shea JJ, (2009) Janus kinases in immune cell signaling. Immunol Rev 228: 273-287.
52. Haura EB, Turkson J, Jove R, (2005) Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2: 315-324.
53. Yang J, Chatterjee-Kishore M, Staugaitis SM, Nguyen H, Schlessinger K, et al. (2005) Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 65: 939-947.
54. Sun S, Steinberg BM, (2002) PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol 83: 1651-1658.
55. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, et al. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333.
56. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, et al. (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582.
57. Zhou Y, Li M, Wei Y, Feng D, Peng C, et al. (2009) Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers. J Interferon Cytokine Res 29: 695-703.
58. Sobti RC, Singh N, Hussain S, Suri V, Bharti AC, et al. (2009) Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population. Mol Cell Biochem 330: 193-199.
59. Schroer N, Pahne J, Walch B, Wickenhauser C, Smola S, (2011) Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Cancer Res 71: 87-97.
60. De Andrea M, Ritta M, Landini MM, Borgogna C, Mondini M, et al. (2010) Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. Cancer Res 70: 7938-7948.
61. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, et al. (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171: 59-76.